A novel mutation in the miR-128b gene reduces miRNA processing and leads to glucocorticoid resistance of MLL-AF4 acute lymphocytic leukemia cells.

A novel mutation in the miR-128b gene reduces miRNA processing and leads to glucocorticoid resistance of MLL-AF4 acute lymphocytic leukemia cells.
复制标题

DOI:
10.4161/cc.9.6.11011
复制
发表时间:
2010-03-15
期刊:
Cell cycle (Georgetown, Tex.)
影响因子:
--
通讯作者:
Lodish HF
Lodish HF
中科院分区:
其他
文献类型:
--
作者:
Kotani A;Ha D;Schotte D;den Boer ML;Armstrong SA;Lodish HF

文献摘要

参考文献

被引文献

相似文献

MLL-AF4急性淋巴细胞白血病预后较差,尽管基于众所周知的概念和方法进行了深入的研究,但这些白血病的发病机制尚不清楚。MicroRNAs(MiRNAs)是一类新的非编码小RNA,它在转录后调节靶mRNA转录本的表达。我们最近报道,在MLL-AF4 ALL中下调的两个miRNAs miR-128B和miR-221的异位表达,通过下调染色体易位产生的MLL-AF4和AF4-MLL嵌合蛋白MLL-AF4和AF4-MLL来恢复糖皮质激素抵抗。在这里,我们报告了在来自MLL-AF4 ALL患者的RS4;11细胞中发现miR-128B的新突变。一种新的突变显著减少了miR-128B的处理。最后,这种碱基改变发生在最初的MLL-AF4 ALL样本中,作为获得性突变。这些结果表明,MLL-AF4中miR-128B的新突变都改变了miR-128B的加工过程,由此导致的成熟miR-128B的下调通过未能下调融合癌基因而导致糖皮质激素抵抗。
MLL-AF4 Acute Lymphocytic Leukemia has a poor prognosis, and the mechanisms by which these leukemias develop are not understood despite intensive research based on well-known concepts and methods. MicroRNAs (miRNAs) are a new class of small noncoding RNAs that post-transcriptionally regulate expression of target mRNA transcripts. We recently reported that ectopic expression of miR-128b together with miR-221, two of the miRNAs downregulated in MLL-AF4 ALL, restores glucocorticoid resistance through downregulation of the MLL-AF4 chimeric fusion proteins MLL-AF4 and AF4-MLL that are generated by chromosomal translocation t(4;11). Here we report the identification of new mutations in miR-128b in RS4;11 cells, derived from MLL-AF4 ALL patient. One novel mutation significantly reduces the processing of miR-128b. Finally, this base change occurs in a primary MLL-AF4 ALL sample as an acquired mutation. These results demonstrate that the novel mutation in miR-128b in MLL-AF4 ALL alters the processing of miR-128b and that the resultant downregulation of mature miR-128b contributes to gluco-corticoid resistance through the failure to downregulate the fusion oncogenes.
DOI: 10.1038/nature03702
发表时间: 2005-06-09
期刊: NATURE
影响因子: 64.8
作者:
Lu, J;Getz, G;Golub, TR
通讯作者: Golub, TR
DOI: 10.1016/s0140-6736(07)61126-x
发表时间: 2007-07-21
期刊: LANCET
影响因子: 168.9
作者:
Pieters, Rob;Schrappe, Martin;Valsecchi, Maria Grazia
通讯作者: Valsecchi, Maria Grazia
DOI: 10.1073/pnas.0602266103
发表时间: 2006-05-02
影响因子: 11.1
作者:
Costinean, S;Zanesi, N;Croce, CM
通讯作者: Croce, CM
DOI: 10.1073/pnas.0506464102
发表时间: 2005-09-27
影响因子: 11.1
作者:
Xia, ZB;Popovic, R;Zeleznik-Le, NJ
通讯作者: Zeleznik-Le, NJ
DOI: 10.1182/blood-2008-12-191619
发表时间: 2009-11-05
期刊: BLOOD
影响因子: 20.3
作者:
Kotani, Ai;Ha, Daon;Lodish, Harvey F.
通讯作者: Lodish, Harvey F.